Evidence map›Paper›PMID 39198486›Full record

ArticleNPJ vaccines2024

Using matrix assisted laser desorption ionisation mass spectrometry combined with machine learning for vaccine authenticity screening.

Rebecca Clarke, Tehmina Bharucha, Benediktus Yohan Arman, Bevin Gangadharan, Laura Gomez Fernandez, Sara Mosca, Qianqi Lin, Kerlijn Van Assche, Robert Stokes, Susanna Dunachie and 9 more

Abstract read
In one paragraph

Article in NPJ vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Rebecca ClarkeDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.ORCID http://orcid.org/0009-0006-5971-3015
Tehmina BharuchaDepartment of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.ORCID http://orcid.org/0000-0002-6772-2855
Benediktus Yohan ArmanDepartment of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.ORCID http://orcid.org/0000-0003-2378-2386
Bevin GangadharanDepartment of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.ORCID http://orcid.org/0000-0002-7466-2977
Laura Gomez FernandezDepartment of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.
Sara MoscaCentral Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, UK Research and Innovation (UKRI), Harwell Campus, Didcot, OX11 0QX, UK.ORCID http://orcid.org/0000-0001-9479-5614
Qianqi LinCentral Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, UK Research and Innovation (UKRI), Harwell Campus, Didcot, OX11 0QX, UK.ORCID http://orcid.org/0000-0001-7578-838X
Kerlijn Van AsscheMedicine Quality Research Group, NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK.ORCID http://orcid.org/0000-0002-9074-7575
Robert StokesAgilent Technologies LDA UK, Didcot, OX11 0RA, UK.
Susanna DunachieMahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.ORCID http://orcid.org/0000-0001-5665-6293
Michael DeatsMedicine Quality Research Group, NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK.
Hamid A MerchantDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, HD1 3DH, UK.ORCID http://orcid.org/0000-0002-7668-5013
Céline CailletMedicine Quality Research Group, NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK.ORCID http://orcid.org/0000-0002-5554-2603
John Walsby-TickleDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.ORCID http://orcid.org/0000-0002-1287-9580
Fay ProbertDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK.ORCID http://orcid.org/0000-0002-8580-2023
Pavel MatousekCentral Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, UK Research and Innovation (UKRI), Harwell Campus, Didcot, OX11 0QX, UK.ORCID http://orcid.org/0000-0003-0912-5339
Paul N NewtonMedicine Quality Research Group, NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK.ORCID http://orcid.org/0000-0003-0734-2022
Nicole ZitzmannDepartment of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.ORCID http://orcid.org/0000-0003-1969-4949
James S O McCullaghDepartment of Chemistry, University of Oxford, Oxford, OX1 3TA, UK. james.mccullagh@chem.ox.ac.uk.ORCID http://orcid.org/0000-0003-4733-1205

Funding

Oxford University | John Fell Fund, University of Oxford (John Fell OUP Research Fund) 0011807Wellcome Trust 222506Wellcome Trust (Wellcome) 222506/Z/21/ZWorld Health Organization (WHO) 2021/1170671-0
6 · The paper itself

Abstract

The global population is increasingly reliant on vaccines to maintain population health with billions of doses used annually in immunisation programmes. Substandard and falsified vaccines are becoming more prevalent, caused by both the degradation of authentic vaccines but also deliberately falsified vaccine products. These threaten public health, and the increase in vaccine falsification is now a major concern. There is currently no coordinated global infrastructure or screening methods to monitor vaccine supply chains. In this study, we developed and validated a matrix-assisted laser desorption/ionisation-mass spectrometry (MALDI-MS) workflow that used open-source machine learning and statistical analysis to distinguish authentic and falsified vaccines. We validated the method on two different MALDI-MS instruments used worldwide for clinical applications. Our results show that multivariate data modelling and diagnostic mass spectra can be used to distinguish authentic and falsified vaccines providing proof-of-concept that MALDI-MS can be used as a screening tool to monitor vaccine supply chains.

Identifiers

PMID39198486
PMCPMC11358428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.